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Ruud CW Vermeulen* and Ineke WG Vermeulen van EckAbstract
Background: The insufficient metabolic adaptation to exercise in Chronic Fatigue Syndrome (CFS) is still being
debated and poorly understood.
Methods: We analysed the cardiopulmonary exercise tests of CFS patients, idiopathic chronic fatigue (CFI) patients
and healthy visitors. Continuous non-invasive measurement of the cardiac output by Nexfin® (BMEYE B.V.
Amsterdam, the Netherlands) was added to the cardiopulmonary exercise tests. The peak oxygen extraction by
muscle cells and the increase of cardiac output relative to the increase of oxygen uptake (ΔQ’/ΔV’O2) were
measured, calculated from the cardiac output and the oxygen uptake during incremental exercise.
Results: The peak oxygen extraction by muscle cells was 10.83 ± 2.80 ml/100ml in 178 CFS women, 11.62 ± 2.90 ml/
100 ml in 172 CFI, and 13.45 ± 2.72 ml/100 ml in 11 healthy women (ANOVA: P=0.001), 13.66 ± 3.31 ml/100 ml in
25 CFS men, 14.63 ± 4.38 ml/100 ml in 51 CFI, and 19.52 ± 6.53 ml/100 ml in 7 healthy men (ANOVA: P=0.008).
The ΔQ’/ΔV’O2 was > 6 L/L (normal ΔQ’/ΔV’O2 ≈ 5 L/L) in 70% of the patients and in 22% of the healthy group.
Conclusion: Low oxygen uptake by muscle cells causes exercise intolerance in a majority of CFS patients, indicating
insufficient metabolic adaptation to incremental exercise. The high increase of the cardiac output relative to the
increase of oxygen uptake argues against deconditioning as a cause for physical impairment in these patients.
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Exercise intolerance is a frequent complaint from patients
who meet the criteria for Chronic Fatigue Syndrome/
Myalgic Encephalitis (CFS) and Idiopathic Chronic Fa-
tigue (CFI) [1].
Objective tests for physical impairment measure the
maximal oxygen uptake (peak V’O2) during a cardiopul-
monary exercise test (CPET) [2-4]. Most studies agree
that peak V’O2 is lower in CFS, but we need to under-
stand the cause of the lower peak V’O2 to explain the
pathogenesis.
The V’O2 depends on the uptake, transport and me-
tabolism of oxygen in the muscle cells during physical
exercise. In most CPET studies in CFS patients, the limi-
tation of peak V’O2 is not attributed to a lower uptake* Correspondence: rv@cvscentrum.nl
CFS/ME Medical Centre Amsterdam, Waalstraat 25-31, Amsterdam 1078BR,
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article, unless otherwise stated.and transport of oxygen to the muscle. A lower meta-
bolic capacity of the muscle cell would change the de-
mand for oxygen and thus lower the oxygen extraction
(C(a-v)O2) and increase the cardiac output relative to
V’O2 (ΔQ’/ΔV’O2) [5,6]. In previous studies we, and
others, did not find impaired mitochondrial activity to
be a cause for a lower peak V’O2 [4,7], but abnormal mito-
chondrial activity was reported by some in CFS and CFI
[8-10].
The aim of the present retrospective study was to de-
termine to what extent the physical impairment in CFS
and CFI was attributable to changes in uptake, transport
and metabolism of oxygen in the muscle cells.Methods
Data was collected from patients who attended the CFS
Medical Centre Amsterdam. The data of sedentary men
and women, physically active less than 1 hour per week,ensee BioMed Central Ltd. This is an Open Access article distributed under the
icense (http://creativecommons.org/licenses/by/2.0), which permits unrestricted
ium, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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visitors to the centre for cardiopulmonary exercise tests,
check-ups and training program advice over the same
period. We obtained information about the health status
of this group, but laboratory tests were not included.
Subjects using medication that could possibly influence
the pulmonary, cardiovascular, immunologic system or
cellular respiration were not included in the study. Chro-
nic fatigue patients were assigned to the CFS or CFI group
according to the criteria of Fukuda [1]. Operational cri-
teria for assignment were: a score of >40 on the fatigue
subscale of the Checklist Individual Strength (CIS-20)
[11], score of ≤ 35 for vitality, ≤ 62.5 for Social Functioning
and ≤50 for Role-Physical on the SF-36 [12] and ≥4 posi-
tive scores (≥7,5) of the additional symptoms of the CDC
Symptom Inventory –DLV [13] for the diagnosis of CFS
and ≤4 positive scores (≥7,5) of the additional symptoms
of the CDC Symptom Inventory –DLV for the diagno-
sis of idiopathic chronic fatigue (CFI) . The cognitive
function of patients was screened with the Shifting Atten-
tional Test Visual of the Amsterdam Neuropsychological
Tasks [14]. Normal Z-score in this test is -2 to +2.
All patients completed a CPET as part of the diagnos-
tic procedure. The protocol of the CPET was described
before [4]. All subjects performed a symptom limited
CPET on a cycle ergometer (Excalibur, Lode, Groningen,
The Netherlands) as described by Wassermann et al.
[15]: 3 min without activity, 3 min of unloaded pedalling,
followed by cycling against increasing resistance until ex-
haustion (ramp protocol) and concluded by 3 min cycling
without resistance. The work rate increase was estimated
from history, physical examination, gender, weight and
height. Verbal encouragement was used to maximise per-
formance during the last phase of incremental exercise.
Exhaustion of the leg muscles was the limiting symptom
in all participants. The V’E, V’O2, V’CO2 and oxygen sat-
uration were continuously measured (Metasoft). The ECG
was continuously recorded and blood pressure was mea-
sured every 2 min. Maximal exercise capacity was ex-
pressed as peak oxygen uptake per kilogram bodyweight
and as percentage of predicted maximal oxygen uptake
[16]. Non-invasive stroke volume measurement by con-
tinuous beat-to-beat pulse contour analysis (Nexfin) was
added to the standard measurements of the CPET [17].
Oxygen extraction and ΔQ’/ΔV’O2 were calculated from
the oxygen uptake and the cardiac output (C(a-v)O2 =
100 × V’O2/ CO and (Q’max-Q’rest)/(V’O2max-V’O2rest))
[18]. All subjects signed an informed consent for the use of
the data for analysis and publication.
Statistical analysis was conducted using the IBM Sta-
tistical Package for the Social Sciences (19.0 for Win-
dows, Chicago, Ill, US). The results were presented as
the mean ± standard deviation (SD). Kolmogorov-Smirnov
tests with Lilliefors significance correction for normalityshowed that the data were normally distributed. Differ-
ences between groups were tested with Analysis of Vari-
ance (ANOVA) and Bonferroni post hoc analysis. Pearson
product-moment correlation coefficient was calculated as
a measure of the strength of the relationship between 2
variables. Statistical significance of two-tailed tests was de-
termined by an alpha level of 0.05.
Results
Data was collected and analysed from a total of 444 sub-
jects who visited the CFS/ME Medical Centre Amsterdam
between June 2008 and June 2013: 203 CFS patients (178
women), 223 CFI patients (172 women) and 18 healthy
visitors (11 women) (Table 1).
Post hoc Bonferroni analysis revealed that the body
weight of healthy males was higher than the body weight
of male CFI patients (P = 0.036, 95% CI: 0.70; 27.95).
Haemoglobin was not different in CFS and CFI pa-
tients (Table 1). In female patients haemoglobin was
not related to O2 extraction (r = 0.077, P = 0.155) or
to the increase of cardiac output relative to oxygen up-
take (ΔQ’/ΔV’O2) (r = -0.008, P = 0.882). In male pa-
tients haemoglobin was related to O2 extraction (r = 0.245,
P = 0.047) but not to ΔQ’/ΔV’O2 (r = -0.140, P = 0.273).
The pulmonary ventilation tests showed no difference
between the CFS, CFI and healthy groups (data not
shown) and the cardiac index was similar in the groups
at any time during the CPET. Blood pressure was within
normal limits in all tests.
At the anaerobic threshold, O2 extraction in healthy
women was higher than in CFS (P = 0.008, 95% CI: 0.378;
3.273). The O2 extraction in healthy men was higher than
in CFS (P = 0.044, 95% CI: 0.064; 6.221) and higher than
in CFI (P = 0.023, 95% CI: 0.355; 6.172).
At peak exercise O2 extraction was higher in healthy
women than in CFS (P = 0.010, 95% CI: 0.49; 4.74) and
higher in CFI than in CFS (P = 0.030, 95% CI: 0.06;
1.52). The O2 extraction was higher in healthy men than
in CFS (P = 0.006, 95% CI: 1.36; 10.36) and higher than
in CFI (P = 0.018, 95% CI: 0.65; 9.13).
The lowest level of O2 extraction at maximal workload
was 10.0 ml/100 ml in the group of healthy women,
5.4 ml/100 ml in CFI and 4.4 ml/100 ml in female CFS
patients. The lowest O2 extraction at maximal workload
in males was 12.5 ml/100 ml in the healthy group, 8.2 ml/
100 ml in the CFI and 6.9 ml/100 in CFS patients.
The increase of cardiac output relative to oxygen up-
take (ΔQ’/ΔV’O2) was lower in healthy women than CFS
(P = 0.011, 95% CI: 0.45; 4.72) and in healthy men than
CFS (P = 0.037, 95% CI: 0.08; 3.58).
In the fatigue patients a low oxygen extraction (≤10 ml/
100 ml) coincided with a increased response time of 2.35 ±
0.19 versus 1.79 ± 0.13 (P = 0.001, 95% CI: -1.19; -0.33) in
the Shifting Attentional test visual of the ANT.
Table 1 Demographic data and results
Female
CFS CFI Healthy ANOVA
n=178 n=172 n=11 P
Age (years) 37.3 ± 12.1 37.9 ± 12.3 42.2 ± 14.8 0.421
Weight (kg) 69.5 ± 15.0 67.5 ± 13.1 68.6 ± 13.2 0.412
BSA (m2) 1.81 ± 0.20 1.78 ± 0.18 1.79 ± 0.17 0.497
Haemoglobin (mmol/l) 8.45 ± 0.55 8.46 ± 0.51 0.846
Rest
HR (beats/min) 96.1 ± 14.9 93.5 ± 16.8 87.7 ± 11.1 0.113
V’O2 (ml/min/kg) 5.46 ± 0.99 5.41 ± 0.93 5.18 ± 0.98 0.635
O2 pulse (ml/beat) 4.00 ± 0.85 3.95 ±0.82 4.09 ± 0.90 0.784
RER 0.86 ± 0.07 0.86 ± 0.07 0.81 ± 0.03 0.073
V’E/V’CO2 34.2 ± 4.3 34.3 ± 4.1 34.7 ± 3.0 0.924
SVI (ml/m2) 42.8 ±7.0 42.3 ±7.6 43.4 ± 10.4 0.797
Cardiac index (L/min/m2) 4.10 ± .081 3.97 ± 0.92 3.80 ± 0.95 0.294
O2 extraction (ml/100ml) 6.48 ± 1.65 6.58 ± 1.72 6.96 ± 1.63 0.620
Anaerobic threshold
HR (beats/min) 112.0 ± 15.6 112.3 ± 15.2 113.3 ± 8.7 0.955
V’O2 (ml/min/kg) 10.9 ± 2.6 11.6 ± 2.7 13.7 ± 3.6 0.001
O2 pulse (ml/beat) 6.75 ± 1.63 6.95 ± 1.67 8.33 ± 2.31 0.009
RER 0.84 ± 0.07 0.85 ± 0.08 0.81 ± 0.06 0.216
V’E/V’CO2 29.7 ± 3.5 28.8 ± 3.5 27.6 ± 1.7 0.025
SVI (ml/m2) 45.7 ± 7.9 45.0 ± 8.2 48.2 ± 11.8 0.382
Cardiac index (L/min/m2) 5.12 ± 1.10 5.11 ± 1.21 5.52 ± 1.64 0.534
O2 extraction (ml/100ml) 8.30 ± 2.08 8.77 ± 2.23 9.86 ± 2.37 0.019
Peak exercise
HR (beats/min) 158.4 ± 19.3 159.6 ± 18.6 164.1 ± 11.3 0.250
V’O2 (ml/min/kg) 20.3 ± 5.0 22.2 ± 5.3 27.4 ± 7.2 0.000
V’O2/pred. % 80.6 ± 17.9 83.1 ± 18.0 105.4 ± 18.8 0.000
O2 pulse (ml/beat) 8.89 ± 2.17 9.26 ± 2.08 11.36 ± 2.89 0.001
RER 1.16 ± 0.10 1.18 ± 0.10 1.20 ± 0.11 0.094
V’E/V’CO2 30.2 ± 3.7 29.7 ± 3.7 27.9 ± 2.4 0.103
SVI (ml/m2) 45.9 ±7.9 45.4 ± 8.3 47.6 ± 11.2 0.797
Cardiac index (L/min/m2) 7.33 ± 1.77 7.39 ± 1.78 7.87 ± 1.96 0.618
O2 extraction (ml/100ml) 10.83 ± 2.80 11.62 ± 2.90 13.45 ± 2.72 0.001
Slope
ΔQ’/ΔV’O2 (L/L) 7.35 ± 2.40 6.80 ± 1.99 5.85 ± 1.23 0.012
Male
CFS CFI Healthy ANOVA
n=25 n=51 n=7 P
Age (years) 41.6 ± 12.3 41.8 ± 9.9 49.4 ± 13.8 0.215
Weight (kg) 88.9 ± 15.7 80.0 ± 12.8 94.3 ± 13.9 0.005
BSA (m2) 2.12 ± 0.21 2.02 ± 0.17 2.19 ± 0.16 0.016
Haemoglobin (mmol/l) 9.34 ± 0.66 9.53 ± 0.56 0.263
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Table 1 Demographic data and results (Continued)
Rest
HR (beats/min) 89.5 ± 15.8 88.4 ± 15.1 79.4 ± 16.2 0.303
V’O2 (ml/min/kg) 5.08 ± 0.81 5.51 ± 0.90 4.57 ± 0.79 0.093
O2 pulse (ml/beat) 5.24 ± 1.20 5.01 ± 0.94 5.56 ± 1.47 0.025
RER 0.84 ± 0.07 0.88 ± 0.08 0.87 ± 0.04 0.226
V’E/V’CO2 33.6 ± 4.4 34.4 ± 5.7 36.5 ± 3.0 0.436
SVI (ml/m2) 43.4 ± 8.0 45.9 ± 6.9 41.2 ± 6.7 0.182
Cardiac index (L/min/m2) 3.86 ± 0.83 4.05 ±0.96 3.31 ± 1.02 0.152
O2 extraction (ml/100ml) 6.96 ± 1.76 6.70 ± 1.68 8.20 ± 2.82 0.124
Anaerobic threshold
HR (beats/min) 103.6 ± 14.6 107.0 ± 14.3 102.1 ± 19.2 0.529
V’O2 (ml/min/kg) 11.8 ± 2.8 13.4 ± 3.3 13.7 ± 3.1 0.093
O2 pulse (ml/beat) 9.97 ± 2.50 9.92 ± 2.49 12.8 ± 3.5 0.025
RER 0.84 ± 0.09 0.87 ± 0.06 0.86 ± 0.08 0.250
V’E/V’CO2 28.0 ± 3.6 26.2 ± 3.0 27.3 ± 3.1 0.089
SVI (ml/m2) 47.5 ± 8.9 51.3 ± 7.0 45.7 ± 6.4 0.049
Cardiac index (L/min/m2) 4.95 ± 1.09 5.48 ± 1.07 4.77 ± 1.44 0.082
O2 extraction (ml/100ml) 9.86 ± 2.02 9.74 ± 3.09 13.0 ± 4.32 0.025
Peak exercise
HR (beats/min) 154.6 ± 19.4 160.5 ± 20.6 151.4 ± 16.2 0.328
V’O2 (ml/min/kg) 24.0 ± 7.2 28.9 ± 7.1 27.3 ± 3.7 0.019
V’O2/pred. % 73.9 ± 17.5 83.4 ± 19.2 96.2 ± 11.4 0.011
O2 pulse (ml/beat) 13.5 ± 3.0 14.2 ± 3.0 17.1 ± 3.0 0.023
RER 1.19 ±0.11 1.24 ± 0.12 1.29 ± 0.06 0.100
V’E/V’CO2 28.9 ± 5.2 27.9 ± 3.8 29.2 ± 4.0 0.537
SVI (ml/m2) 47.4 ± 10.5 50.4 ± 9.4 44.4 ± 8.6 0.182
Cardiac index (L/min/m2) 7.44 ±2.13 8.02 ± 2.07 6.45 ±1.81 0.136
O2 extraction (ml/100ml) 13.66 ± 3.31 14.63 ± 4.38 19.52 ± 6.53 0.008
Slope
ΔQ’/ΔV’O2 (L/L) 5.84 ± 1.82 5.38 ± 1.63 4.01 ± 1.26 0.043
Demographic data and results of cardiopulmonary exercise tests in patients with chronic fatigue syndrome, idiopathic chronic fatigue and healthy humans during
rest, at the anaerobic threshold and maximal workload. BSA: body surface area, HR: heart rate, V’O2: oxygen uptake, V’O2/pred.: oxygen uptake as percentage of
predicted, SVI stroke volume index, ΔQ’/ΔV’O2: increase of cardiac output relative to the increase of oxygen uptake.
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The lower maximal exercise capacity (peak V’O2) of CFS
and CFI patients was related to a lower oxygen uptake
of the muscle cells (C(a-v)O2) and a higher increase of
cardiac output relative to V’O2 (ΔQ’/ΔV’O2) than in
healthy men and women.
The lower peak V’O2 was not explained by an impair-
ment of ventilation. The stroke volume and cardiac out-
put increased during the exercise test, but at no level of
effort a consistent difference was seen between the three
groups, indicating a normal adaptation of the heart to
increasing workload in CFS patients. This result was in
accordance with previous studies [2,4,19]. Stroke volume
in men (n = 83) during exercise test was not differentfrom reported values by Nexfin [17], gas rebreathing [5]
and impedance cardiography [20]. Resting values were
78.9 ± 12.8 ml in this study, 80 ± 9 ml by Nexfin and
73.8 ± 10.1 ml by impedance cardiography and at peak
100.7 ± 18.0 ml in this study, 107.5 ± 7.2 ml by gas re-
breathing and 97.9 ± 6.4 ml by impedance cardiography.
Peak cardiac output in men was 192.0 ± 92.9 ml/kg/min
in this study and 212 ± 37 ml/kg/min by acetylene re-
breathing [6].
We have no haemoglobin data of the healthy visitors.
It is possible that the haemoglobin values of patients, al-
though within normal limits [21], were lower than the
values of healthy visitors. The mean value of the healthy
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Figure 1 The peak oxygen uptake as percentage of predicted
relative to the peak oxygen extraction. Vertical line: predicted
peak oxygen uptake. Horizontal line: lowest oxygen extraction
reported for healthy humans. No-CFS: Idiopathic Chronic Fatigue,
CFS Chronic Fatigue Syndrome.
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rence of O2 extraction by a difference of haemoglobin
[15]. A high cardiac index, caused by low haemoglobin
would also have been present during rest [22], but we
found no difference between the 3 groups. In men haemo-
globin correlated with oxygen extraction, but explained
only 6% of the variance at peak V’O2.
The oxygen extraction increases during incremental
exercise and a lower value of peak oxygen extraction in
the CFS and CFI groups might be attributed to insuffi-
cient effort, caused by lack of motivation. This, however,
would not explain the lower oxygen extraction at the
anaerobic threshold and the higher slope of the ΔQ’/
ΔV’O2. Another cause for the lower V’O2 in CFS and
CFI could be the deconditioning in these patients, but
the value of the increase of cardiac output relative to the
oxygen uptake (ΔQ’/ΔV’O2) is independent from moti-
vation and deconditioning [6] (normal ΔQ’/ΔV’O2 ≈ 5).
The most probable cause for the low peak V’O2, the
low oxygen extraction and the high ΔQ’/ΔV’O2 in CFS
and CFI patients was an attenuated cell metabolism. The
low oxygen extraction during exercise was also reported
in mitochondrial pathology [6], systemic lupus erythema-
tosus [23], HIV [5] and myophosphorylase deficiency [24].
This result is also not in contradiction to the abnormal
proton handling that was reported during and after ces-
sation of exercise in CFS patients [25,26].
The peak oxygen extraction in men and women who
performed at the same level or better than the reference
population of sedentary healthy subjects [27] was never
less than 10 ml/100 ml as reported for healthy male
subjects [28] (Figure 1). The same lower limit of 10 ml/
100 ml was also reported in heart failure patients [29].
The O2 extraction of healthy participants in this study
was higher than 10 ml/100 ml (Figure 1). The mean O2
extraction at maximal workload in fatigue patients was
much lower and comparable to asymptomatic HIV in-
fected individuals (10.8 ± 0.5 ml/100 ml) [5].
The peak V’O2 of 73 CFS patients and 59 CFI patients
was the same as or higher than the mean peak V’O2 of
healthy sedentary people [27]. All CFS and CFI patients,
however, experienced a physical impairment that was se-
vere enough for the diagnosis. The conclusion must be
that the subjective experience of physical impairment and
the objective peak V’O2 in the CPET are not identical.
If the mitochondrial system is intact in CFS patients
[4], the low oxygen extraction in a subgroup of CFS
patients may indicate a downregulation of the activity
in vivo. A downregulation by a factor that is involved in
the activity of the immune system would explain the
same phenomenon in SLE [23], different from damaged
mitochondria in HIV [5,30]. The lower oxygen extraction
and higher ΔQ’/ΔV’O2 however do not differentiate be-
tween down regulation of cell metabolism and congenitalor acquired mitochondrial pathology in CFS patients. The
abnormal results of the Shifting Attentional test visual of
the ANT suggest that the impaired oxygen uptake is not
limited to the muscle cells.Limitations
The validity of the results of this retrospective observa-
tional study is limited by the uncontrolled inclusion of
the participants. The exercise protocol for healthy visi-
tors was not different from the protocol for fatigued pa-
tients but we have no laboratory data of healthy visitors.
Therefore we cannot exclude less than optimal results in
this group due to unknown diseases. The accuracy and
precision of the assessment of stroke volume by Nexfin
in CFS patients during CPET was not reported yet. For ac-
curacy we used the data of comparable studies in healthy
subjects, the results of a study of repeated CPET’s is nee-
ded for the assessment of precision. We cannot exclude
influence of haemoglobin on the oxygen transport capa-
city of the blood in healthy visitors.Conclusions
CPET with continuous measuring of cardiac output by
Nexfin allowed for the calculation of the presence and
severity of metabolic causes of exercise intolerance. This
retrospective study showed that a low oxygen extraction
and a high ΔQ’/ΔV’O2 were consistent with a metabolic
cause for exercise intolerance in 70% of CFS patients.
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